Anticipated
as well as recently launched global Bioresorbable Coronary Stents Market will trigger
a revenue increase to USD 247 million by 2025. According to a new report by
Grand View Research, Inc., better device attributes of second-generation
coronary stents will provide the ascending push to this market.
Bioresorbable
stents are intended majorly for the young adult population, whereby these
individuals are enabled with a normal functioning artery following complete
resorption of the dissolvable devices.Lifestyle diseases and prevalence of
associated risk factors underpin the growth in atherosclerosis-related cardiac
events. This drives the global disease prevalence in young adults as well as
the high volume of elective Percutaneous Coronary Interventions (PCI).
What
sets the second-generation bioresorbable coronary stents apart? – Learning from
past mistakes, manufacturers have developed new generation bioresorbable with
thinner strut thicknesses, faster resorption times, and better radial force.
Amaranth, with a single-minded focus on strut thickness, has developed three
such devices. Each with a thinner strut. The latest, Magnitude boasts of 100
microns.
Another
factor providing a fillip to this market is the less-invasive nature of PCIs as
compared to coronary artery bypass grafting, resulting in their high elective
procedure volume. In most parts of the world, lack of auditing to check
inappropriate surgeries drives the number of coronary stenting procedures.
Hence, this market is expected to witness growth due to the high volume of
elective PCI, particularly in APAC and Europe.
Browse
Details of Report @
http://www.grandviewresearch.com/industry-analysis/bioresorbable-coronary-stents-market
http://www.grandviewresearch.com/industry-analysis/bioresorbable-coronary-stents-market
Further Key Findings From the Study Suggest:
- Europe
region is the major contributor for the bioresorbable stents market in
2016. Subsequent to withdrawal of the bioresorbable Absorb BVS, emergence
of CE-approved bioresorbable stents hold strong growth prospects for
greater sales in the member countries.
- APAC follows
Europe with almost 30% segment share and is expected to record the fastest
growth in the future
- Absorb BVS,
among the key brands, engendered the highest sales revenue in 2016, while
Absorb 2nd generation device will supersede the sales of
its rival devices toward the end of the forecast period
- North
America trails behind as the smallest revenue generator against leading
counterparts, Europe and APAC, in this market. Downfall of Abbott’s Absorb
BVS, the only approved FDA device, is the underlying reason for the small
segment share in the U.S. region.
- Key players
in this space include BIOTRONIK, Meril Lifesciences Pvt. Ltd., Abbott,
Elixir Medical Corporation, REVA Medical, Arterial Remodeling
Technologies, and Amaranth Medical
- Strategic
efforts undertaken by the companies to gain a higher market share center
on bioresorbable coronary stents development. Companies targeting the
clinical pipeline have developed second-generation bioresorbable products
with better design specifications, such as devices with thinner strut
thicknesses and faster absorption rates that gain comparability with the
gold standard, drug-eluting metallic stents.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment